Silverarc Capital Management, LLC Rezolute, Inc. Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$0.95 - $2.55 $4,845 - $13,005
-5,100 Reduced 3.25%
151,985 $387,000
Q4 2023

Feb 14, 2024
SELL
$0.74 - $1.24 $204,354 - $342,432
-276,155 Reduced 63.74%
157,085 $155,000
Q3 2023

Nov 13, 2023
SELL
$1.32 - $2.1 $87,521 - $139,238
-66,304 Reduced 13.27%
433,240 $571,000
Q2 2023

Aug 14, 2023
BUY
$1.75 - $2.33 $874,202 - $1.16 Million
499,544 New
499,544 $989,000

Others Institutions Holding RZLT

# of Institutions
62
Shares Held
38.5M
Call Options Held
1.6K
Put Options Held
24.6K
View Full List

About Rezolute, Inc.

RZLT Quotes by TradingView
  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $172M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email